The global Antiemetics for Cancer Treatment market was valued at US$ 6.5 billionin 2023 and is projected to reach US$ 8.7 billionby 2030, at a CAGR of 4.3% during the forecast period.

The USA market for Global Antiemetics for Cancer Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Antiemetics for Cancer Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Antiemetics for Cancer Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.

Serotonin Receptor Antagonists Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Antiemetics for Cancer Treatment include Heron Therapeutics, Inc, Sandoz International GmbH, Merck & Co., Inc, Eisai Co., Ltd, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd, Mylan N.V, GSK plc and Mundipharma International, etc. in 2023, the global top five players have a share approximately % in terms of revenue.

Emetogenic symptoms are associated with nausea and vomiting associated with cancer treatments such as chemotherapy, radiation therapy, and drug therapy. Nausea and vomiting are major side effects of cancer treatment. It is important that nausea and vomiting are controlled so patients can continue treatment and have a better quality of life. Nausea and vomiting, primarily due to, can also be induced in patients receiving chemotherapy and radiation therapy of the brain, gastrointestinal tract, or liver.

This report aims to provide a comprehensive presentation of the global market for Antiemetics for Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiemetics for Cancer Treatment. This report contains market size and forecasts of Antiemetics for Cancer Treatment in global, including the following market information:

Global Antiemetics for Cancer Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)

Global Antiemetics for Cancer Treatment Market Sales, 2019-2024, 2025-2030, (K Units)

Global top five Antiemetics for Cancer Treatment companies in 2023 (%)

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antiemetics for Cancer Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antiemetics for Cancer Treatment Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)

Global Antiemetics for Cancer Treatment Market Segment Percentages, by Type, 2023 (%)

• Serotonin Receptor Antagonists
• Neurokinin-1 Receptor Antagonist
• Corticosteroids
• Olanzapine
• Other

Global Antiemetics for Cancer Treatment Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)

Global Antiemetics for Cancer Treatment Market Segment Percentages, by Application, 2023 (%)

• Highly Emetogenic Chemotherapy
• Moderately Emetogenic Chemotherapy
• Low Emetogenic Chemotherapy

Global Antiemetics for Cancer Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)

Global Antiemetics for Cancer Treatment Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

The report also provides analysis of leading market participants including:

• Key companies Antiemetics for Cancer Treatment revenues in global market, 2019-2024 (Estimated), ($ millions)
• Key companies Antiemetics for Cancer Treatment revenues share in global market, 2023 (%)
• Key companies Antiemetics for Cancer Treatment sales in global market, 2019-2024 (Estimated), (K Units)
• Key companies Antiemetics for Cancer Treatment sales share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Heron Therapeutics, Inc
• Sandoz International GmbH
• Merck & Co., Inc
• Eisai Co., Ltd
• Teva Pharmaceutical Industries Ltd
• F. Hoffmann-La Roche Ltd
• Mylan N.V
• GSK plc
• Mundipharma International
• Baxter
• Bayer AG
• Cipla Inc
• Sanofi
• Sun Pharmaceutical Industries Ltd
• Qilu Pharmaceutical Co.,Ltd

Outline of Major Chapters:

Chapter 1: Introduces the definition of Antiemetics for Cancer Treatment, market overview.

Chapter 2: Global Antiemetics for Cancer Treatment market size in revenue and volume.

Chapter 3: Detailed analysis of Antiemetics for Cancer Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antiemetics for Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Antiemetics for Cancer Treatment capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Table of content

1 Introduction to Research & Analysis Reports
1.1 Antiemetics for Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiemetics for Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiemetics for Cancer Treatment Overall Market Size
2.1 Global Antiemetics for Cancer Treatment Market Size: 2023 VS 2030
2.2 Global Antiemetics for Cancer Treatment Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Antiemetics for Cancer Treatment Sales: 2019-2030
3 Company Landscape
3.1 Top Antiemetics for Cancer Treatment Players in Global Market
3.2 Top Global Antiemetics for Cancer Treatment Companies Ranked by Revenue
3.3 Global Antiemetics for Cancer Treatment Revenue by Companies
3.4 Global Antiemetics for Cancer Treatment Sales by Companies
3.5 Global Antiemetics for Cancer Treatment Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Antiemetics for Cancer Treatment Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Antiemetics for Cancer Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antiemetics for Cancer Treatment Players in Global Market
3.8.1 List of Global Tier 1 Antiemetic

CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414